Medtronic Inc. recently announced the initiation of the first investigational sites in the U.S. to participate in PROTECT, the company’s global study comparing the Endeavor and Cypher drug-eluting stents on key safety metrics, including stent thrombosis – a rare but serious adverse event in which a blood clot forms inside the stent, with the potential to cause heart attack or death.

Medtronic Inc. will showcase its Export Aspiration Catheter at TCT 2008. Recent results from an independent study, called TAPAS, showed that thrombus aspiration with the Export Aspiration Catheter prior to stenting can improve blood flow and survival rates in patients suffering acute myocardial infarction (AMI) compared to treatment with percutaneous coronary intervention (PCI) alone.

Medtronic Inc. will feature its FDA-cleared Talent Abdominal Stent Graft on the CoilTrac Delivery System for the treatment of abdominal aortic aneurysms.

August 25, 2008 - Vermillion Inc. said last week a study published in the August 2008 issue of the journal Vascular Medicine included data supporting its peripheral artery disease (PAD) diagnostic program.

The study was led by John Cooke, M.D., Ph.D., professor of medicine at Stanford University and involved researchers at Stanford, Mt. Sinai Medical Center (New York) and Vermillion.

August 25, 2008 - A study conducted by the Cardiovascular Research Institute, Washington Hospital Center, Washington, D.C. indicates both drug-eluting stents (DES) and bare metal stents (BMS) for catheter-based treatment of saphenous vein graft (SVG) stenoses provide acceptably safe and efficacious results, but unlike the case in native coronary arteries, DES use does not reduce the frequency of the need for repeat revascularization.

The study is published in the Sept. 1 issue of the American Journal of Cardiology.

August 25, 2008 - Starion Instruments said a study recently presented at the 2008 Annual Scientific Meeting of the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) found Starion’s Tissue Ligating Shears provides a safe and effective solution for endoscopic harvesting of the radial artery and saphenous vein.

August 25, 2008 – Results published in the August issue of the peer-reviewed journal Vascular Medicine, support Vermillion Inc.’s peripheral artery disease (PAD) diagnostic program, the molecular diagnostics company said.
The study was led by John Cooke, M.D., Ph.D., professor of medicine at Stanford University and involved researchers at Stanford, Mt. Sinai Medical Center (New York) and Vermillion.

August 25, 2008 - Concerns over problems with MRIs often not being properly cleaned and leading to the spread of Methicillin resistant Staphylococcus aureus (MRSA) during radiological scans is addressed in a recently released paper titled "Preventing Infection in MRI: Best Practices for Infection Control in and Around MRI Suites."

Neovasc (formerly Angiometrx) is the developer of the Metricath System, an arterial and in-stent measurement device that assists physicians with optimal stent size selection and helps confirm optimal stent expansion during the treatment of coronary and peripheral artery disease.

Accumetrics develops and manufactures the VerifyNow System, a comprehensive system for the assessment of platelet function.

VerifyNow provides doctors with an easy to use, automated, rapid and accurate way to monitor platelet function to optimize the effectiveness of antiplatelet therapies. Accumetrics markets VerifyNow tests for aspirin, Plavix and GPIIb/IIIa inhibitors.

August 2008

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now